Is this a steady consumer brand business?
Kenvue Inc is a consumer products company selling everyday health and personal care items. Its business is built around branded products that are purchased frequently and distributed broadly through retail channels. The company operates at large scale, with a market value around USD 34 billion and roughly 1.9 billion shares outstanding.
Are margins and returns holding up?
FundamentalsIn its latest annual filing, reported in USD, Kenvue held USD 1.1 billion of cash against USD 8.5 billion of total debt. Over the period, revenue was USD 15.1 billion, alongside EBIT of USD 2.4 billion and net income of USD 1.5 billion.
Profitability remained supported by a 58.85% gross margin and a 17.15% operating margin, with a 10.61% net profit margin. Capital spending was USD 475 million versus USD 557 million of depreciation and amortization, and the company’s cash flow proxy was about USD 2.0 billion. Revenue declined 2.1% year over year, while ROE over the trailing period was 15.18%.
Is the stock trading below fair value?
DCF / MultiplesAt USD 17.71, the stock trades near the lower end of the DCF range and below the central case. The trading multiples alongside that setup include about 20.96x earnings and 13.05x EV/EBITDA (TTM).
Balance Sheet Drives the Risk
TakeawayThe balance sheet is the main pressure point, not the margins. Returns on capital look modest against the capital tied up. The case works if cash generation stays consistent. Debt becomes a problem if profits soften or reinvestment needs rise.